Skip to main content
COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC:
Get the latest research information from NIH:

Profile Image

Senior Investigator

Amy Hauck Newman, Ph.D.

Molecular Targets and Medications Discovery Branch
Room 3444
333 Cassell Drive
Baltimore MD 21224-
Office: (443) 740-2887

Fax: (443) 740-2111

Dr. Newman received her Ph.D. in medicinal chemistry from the Medical College of Virginia, where she designed, synthesized and behaviorally evaluated novel amphetamine analogues. During postdoctoral training at NIDDK, she extending her experience with opiate total synthesis and also developed PET ligands for opioid receptor imaging. After a short tenure at Walter Reed Army Institute of Research, she initiated a Medicinal Chemistry Program at NIDA, in Baltimore. Her research focuses on the design and synthesis of molecular tools to elucidate drug-receptor interactions in the brain and induce changes at the protein level to affect behavior. Dr. Newman is currently studying the roles of the dopamine and serotonin transporters, the dopamine D2 receptor family, and mGluR5 in addiction, aiming to develop medications for treatment.

Staff Image